Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH
Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia[*]
Margaret V. Ragni
1
Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
2
Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, USA
,
Rachel C. Jankowitz
1
Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
,
Kristen Jaworski
2
Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, USA
,
Elizabeth P. Merricks
3
Department of Pathology and Laboratory Medicine/ Francis Owen Blood Research Laboratory, University of North Carolina, Chapel Hill, North Carolina, USA
,
Mark T. Kloos
3
Department of Pathology and Laboratory Medicine/ Francis Owen Blood Research Laboratory, University of North Carolina, Chapel Hill, North Carolina, USA
,
Timothy C. Nichols
3
Department of Pathology and Laboratory Medicine/ Francis Owen Blood Research Laboratory, University of North Carolina, Chapel Hill, North Carolina, USA